Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004733 · ClinicalTrials.gov registry record · Phase 3
Timing of Levodopa Treatment in Parkinson's Disease
A Phase 3 study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- Phase 3
- Development phase
NCT00004733 is a Phase 3 study that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS).
The verdict
NCT00004733, a Phase 3 study, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The ELLDOPA study is a controlled clinical trial in patients with newly diagnosed PD to determine the optimal timing and dosing with levodopa (Sinemet or its generic equivalents).
Interventions
- DRUG levodopa
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-01 |
| Est. Completion | 2004-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004733
The ClinicalTrials.gov registry entry for NCT00004733 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which levodopa is the first listed.
NCT00004733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004733 about?
NCT00004733 is a clinical study titled "Timing of Levodopa Treatment in Parkinson's Disease". The ELLDOPA study is a controlled clinical trial in patients with newly diagnosed PD to determine the optimal timing and dosing with levodopa (Sinemet or its generic equivalents).
What is the current status of trial NCT00004733?
This trial is currently completed. It is a Phase 3 study. The study started on 1998-01. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00004733?
The interventions under investigation include: levodopa (DRUG).
Who is sponsoring clinical trial NCT00004733?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.